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The pristine formation of complex organs depends on sharp temporal and spatial
control of gene expression. Therefore, epigenetic mechanisms have been frequently
attributed a central role in controlling cell fate determination. A prime example for this
is the first discovered and still most studied epigenetic mark, DNA methylation, and
the development of the most complex mammalian organ, the brain. Recently, the field
of epigenetics has advanced significantly: new DNA modifications were discovered,
epigenomic profiling became widely accessible, and methods for targeted epigenomic
manipulation have been developed. Thus, it is time to challenge established models of
epigenetic gene regulation. Here, we review the current state of knowledge about DNA
modifications, their epigenomic distribution, and their regulatory role. We will summarize
the evidence suggesting they possess crucial roles in neurogenesis and discuss whether
this likely includes lineage choice regulation or rather effects on differentiation. Finally, we
will attempt an outlook on how questions, which remain unresolved, could be answered
soon.
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DNA METHYLATION AND OTHER FORMS OF DNA
MODIFICATIONS
In 1948, Rollin Hotchkiss used paper chromatography to separate and quantify the components of
DNA. To his surprise he detected not only the four nucleo-bases thymine, adenine, cytosine, and
guanine, but also a “minor constituent designated epicytosine [with] a migration rate somewhat
greater than that of cytosine” (Hotchkiss, 1948). As Hotchkiss had already suspected, epicytosine
turned out to be a methylated form of cytosine. Thus, the first description of an epigenomic mark
occurred only few years after DNA has been identified as the carrier of genetic information (Avery
et al., 1944) and years before its structure has been resolved (Watson and Crick, 1953). Coincidently
to these biochemical insights, first conceptual ideas arose attempting, to explain, how a single
set of genetic information could give rise to the pleiotropy of cellular phenotypes (Waddington,
1957). From these early days on, epigenomic marks and epigenetic phenotypes have been closely
intertwined, which lead to great discoveries but also to misconceptions, such as the perception,
these two terms, epigenetic (“heritable traits that have their origin not in the DNA sequence”) and
epigenomic (“reversible marks, modifications and features of DNA-implicated in epigenetic traits”)
would be equivalent.
Today we know that many more DNA modifications exist. Additionally to the mark
usually meant by the phrase “DNA methylation” [the methylation of cytosine at position C5
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(C5-methylcytosine, 5mC)], the same base can also occur
methylated on other positions [e.g., N3-methylcytosine (3mC)].
3mC is, however, thought to represent rather a product of
DNA damage than a bona fide information carrier (Sadakierska-
Chudy et al., 2015). But not only cytosine can be targeted
by methylation, also adenine [N6-methyladenine, (6mA); (Wu
et al., 2016)]. On top, new DNA modifications on the position
C5 have been discovered recently, which are generated by
DNA demethylation pathways (Booth et al., 2015, Figure 1).
The first of these 5mC oxidation products to be reported was
5hmC (C5-hydroxymethylcytosine) (Kriaucionis and Heintz,
2009; Tahiliani et al., 2009); 5fC (C5-formylcytosine), and 5caC
(C5-carboxylcytosine) followed later. Although 5hmC has been
described to occur in animal tissues (e.g., mouse brains) already
in the 70s (Penn et al., 1972), its relevance was not recognized as
it was widely interpreted as a product of DNA damage (Privat
and Sowers, 1996). Today we know that 5hmC and 5caC are
not necessarily transient marks occurring solely in a sequence of
chemical reactions; instead they can appear quite stable at least
under some circumstances (Bachman et al., 2014, 2015).
In the following, we will give a short overview about the
distribution of DNA modifications and discuss how they are
established. We will then present the suggested roles for DNA
modifications in gene expression control and review how those
have been implicated into regulating lineage decisions during
brain development. We finish with re-evaluating the scientific
evidence for DNA methylation marks controlling neurogenesis
and discuss recent technical advances to study their function
at precise sites in the genome. Although we mention several
biological processes and all known DNA modifications in this
review, we will focus on the role C5-methylcytosine plays in
neurogenesis and neuronal maturation.
EPIGENOMIC DISTRIBUTIONS OF DNA
MODIFICATIONS
Although DNA modifications are common in bacteria (e.g.,
m6A, N6-methyladenine; m5C, C5-methylcytosine; m4C,
FIGURE 1 | Chemical structures of DNA modifications: five DNA modifications and relevant enzymes are depicted. DNMTs methylate 5C resulting in 5mC, which can
be further modified by TET enzymes to 5hmC, 5fC, and 5caC. Enzymes of the TDG/BER pathway have been implicated in removal of the DNA modifications.
C4-methylcytosine) (Chen et al., 2014), many eukaryotic model
systems have no or only traces of 5C methylation. Neither
Saccharomyces cerevisiae nor Caenorhabditis elegans possess this
epigenomic mark (Shin et al., 2014). In Drosophila melanogaster
it is very rare and has only lately been confirmed (Lyko et al.,
2000). This remarkable absence of canonical DNA methylation
in the three most frequently used genetic model systems might
be one reason its universal significance for gene expression and
cellular phenotypes is still not known. Consequently, today,
70 years after its discovery, the discussion about how frequent
functional DNA methylation marks are, is still ongoing (Stricker
et al., 2017). In this context it should be mentioned, however,
that the genomes of Caenorhabditis elegans and Drosophila
melanogaster have recently shown to possess significant levels of
m6A (Greer et al., 2015; Zhang et al., 2015).
In mammalian cells m5C is rather frequent it occurs mainly
in pairs of CpGs, in which between 80 and 90% of cytosines
are methylated (Hon et al., 2013). Interestingly, those 10–20%
CpGs found to be unmethylated are not distributed randomly
throughout the genome, but concentrate on so called CpG
islands, which mostly coincide with gene promoters. Indeed,
around half of mammalian transcripts begin in a CpG island
(Bird, 2002). Until recently, it was believed that 5mC occurs in
mammalian cells exclusively in the CpG context. That this is not
necessarily the case has been shownwith the help of newmethods
for epigenomic analysis of DNA modifications (Figure 2): first,
in human pluripotent stem cells, in which 25% of m5C occurs
at CpH sites (with H = A, C, or T) (Lister et al., 2009), later
this has been found also in (mouse and human) brain samples.
Other tested somatic cells are, as far as we know, mostly devoid
of such non-CpG methylation as far as we know (Xie et al.,
2012; Lister et al., 2013). Similarly to non-CpG methylation,
C5-hydroxymethylcytosine has also been first described in DNA
derived from pluripotent and brain cells (Kriaucionis andHeintz,
2009; Tahiliani et al., 2009). Especially hypothalamus, cerebral
cortex, and hippocampus have been reported to be rich sources of
hm5C (Munzel et al., 2010), occurring almost at the rate of one
sixth of m5C (Shin et al., 2014), often on enhancers (Yu et al.,
2012). N6-methyladenine was found in mouse ES cells, in which
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FIGURE 2 | Common methods for widespread detection of DNA modifications. (A) Conversion based detection methods. Bisulfite (BS) sequencing, oxidative bisulfite
(oxBS) sequencing, and Tet assisted BS (TAB) sequencing enable the epigenomic distinction of 5C, 5mC, and 5hC, while similar techniques separating 5fC and 5caC
have been developed as well (Plongthongkum et al., 2014). Sequence below indicates readout expected in NGS. For comprehensive analysis of DNA modifications
several detection methods must be combined. (B) Antibody based detection methods. DNA Immunoprecipitations (DIP) using modification specific antibodies allow
the quantitative analysis of epigenomic distribution (making use of NGS or arrays). meDIP (methylated DNA immunoprecipitation) has been the archetype of this
methodology (Weber et al., 2005), but several variants for other DNA modifications have been reported as well recently (comprehensively reviewed in Plongthongkum
et al., 2014).
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it occurs particularly on young LINE elements; they themselves
are enriched on the X-chromosome (Wu et al., 2016).
ESTABLISHMENT AND REMOVAL OF DNA
MODIFICATIONS
DNA methylation is catalyzed by a group of enzymes, the DNA
methyltransferases, which catalyze the transfer of a methylation
residue from S-adenosyl-L-methionine to C5 of cytosine. In
mammals these consist of Dnmt3a and Dnmt3b, the de novo
methyltransferases and Dnmt1, that maintains methylation
through the cell cycle by copying CpG methylation patterns
from the mother to the newly synthesized strand. Rodents have
recently been shown to possess an additional de novo DNA
methyltransferase, Dnmt3c, evolved through a gene duplication
of Dnmt3b (Barau et al., 2016). The mammalian enzyme
responsible for adenine methylation is currently unknown.
Dnmt3a has been reported to occur in two different forms, due
to alternative promoter usage. Although this is not uncommon
for protein coding genes, it might be relevant for the methylome,
since in cell lines Dnmt3a1 (the full length protein) and
Dnmt3a2 (the short isoform) have been reported to occupy very
different locations in chromatin.While Dnmt3a1 is foundmainly
in heterochromatin, Dnmt3a2 is associated with euchromatic
regions (Chen et al., 2002). The two remaining members of the
Dnmt family, 3L and 2, are paralogs, which either lost enzymatic
activity or methylate RNA (Goll et al., 2006; Ooi et al., 2007).
While the de novo enzymes Dnmt3a and Dnmt3b are necessary
to set DNA methylation marks (on CpG and likely also non-
CpG positions) (Guo et al., 2014), Dnmt1 ensures its long term
inheritance. It is acting on hemi-methylated DNA, occurring
after DNA replication (or DNA repair) and transfers a methyl
group to the cytosine on the unmethylated strand. Obviously,
this depends on the palindromic base composition of CpG di-
nucleotides. mCpH sites lack a cytosine residue on the second
DNA strand and thus, are certainly asymmetrically inherited
to the progeny of pluripotent and neural stem cells. Whether
this has however, any functional consequence has remains to be
shown.
That Dnmt1 constantly antagonizes passive DNA
demethylation is widely accepted. Whether there are any
active processes selectively removing DNA methylation marks
from certain epigenomic locations has been a controversial issue
for a long time. Over the last decades there have been a series of
reported findings of DNA demethylases (wittily summarized by
Ooi and Bestor, 2008). In contrast to those, recent candidates
have been received more favorably (Wu and Zhang, 2010).
Today it is widely accepted, that a number of enzymes contribute
on the de-methylation of 5mC. First of all the members of the
ten-eleven translocation family of enzymes (Tet1, Tet2 and Tet3)
oxidize 5mC to 5hmC. But Tet activity does not necessarily
stop at this point, as these enzymes can further oxidize 5hmC
to 5fC and subsequently to 5caC (Figure 1) (He et al., 2011; Ito
et al., 2011). These marks are then thought to be lost passively or
removed by the thymine DNA glycosylase (TDG), a forerunner
of the base excision repair (BER) (Yu et al., 2012; Zhang et al.,
2012). Also other proteins and enzymes involved in DNA repair
(e.g., GADD45/AID/APOBEC) have frequently been implicated
in active DNA de-methylation (Rai et al., 2008; Bhutani et al.,
2010, 2011), although their contributions to global methylomic
changes are still being discussed (Nabel et al., 2012).
GENERAL CONCEPTS FOR POTENTIAL
FUNCTIONS OF DNA MODIFICATIONS
DNA methylation has been implied in regulation of gene
transcription already in the late 60s (Harrisson, 1971; Scarano,
1971; Holliday and Pugh, 1975; Riggs, 1975) and often still
is; although it has become clear that it likely plays a much
less general role than believed originally. But why has DNA
methylation become the one epigenomic mark most frequently
connected to epigenetic gene silencing in the first place? There
are plenty of answers to this question, which we are neither
able to discuss fairly, nor to list comprehensively; we think
however, that most of the concepts and experimental evidence
gained during the decades can be grouped into four types,
which we will address below. First, the biochemical features
of DNA methylation, its life cycle and inheritance make it a
prime candidate for a developmental epigenetic mark; second,
global correlations between the presence of DNA methylation
and the activity state of DNA in the nucleus do occur; third,
DNA methylation is necessary for normal animal development
and finally, on some individual model loci a functional effect of
DNA methylation on restricting transcription is clearly evident.
Hereafter, we will discuss the evidence for the above criteria
in establishing the previous model, namely a role of DNA-
methylation in repressing alternative fates. Subsequently we will
proceed to discuss experimental evidence testing thismodel. Data
from pluripotent stem cell differentiation and mouse models in
vivo (section Mouse Models) demonstrate that no fate switch to
an alternative fate occurs even when most or all of methylation
marks have gone (see section Mouse Models). Conversely,
phenotypes appear late in brain development, often at postnatal
stages, indicating rather that maturation processes are affected
(Tables 1, 2).
The Life Cycle of DNA Methylation Levels
and Its Inheritance
Since decades it is relatively undisputed that mammalian
development has to provide a molecular memory restricting
the options of each individual cell to express or adopt cell
identities. Until recently, cellular potency was believed to be a
one way street, with continuously less choices as development
progresses. This has been put in a nutshell by the iconic depiction
of the epigenetic landscape conceived by Waddington (1957).
Although we know today, that we can revert development
(Takahashi and Yamanaka, 2016) or provide direct shortcuts
(Masserdotti et al., 2016), the basic question remains: What
informs and restricts cellular identity during development? Very
early on DNA methylation has been considered to be the prime
candidate fulfilling this role. The reason for this has much to do
with the dynamics of the mark itself as m5C is a quite stable
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TABLE 1 | Published knockout mouse models and their reported phenotype during brain development and in the adult brain.
Gene Type of Mutant Cells/Time Phenotype References
Dnmt1 Nestin-Cre NPCs/E12 Premature glial marker induction, neuron loss. Fan et al., 2005
CamK-Cre Neurons No obvious effect. Fan et al., 2001
Nestin-CreERT2 NPC/adult Decreased survival of hippocampal neurons. Noguchi et al., 2015
CamK2a-Cre93 Excitatory neurons in the mouse
forebrain
Deficits in learning and memory (+Dnmt3a). Feng et al., 2010
Emx1-Cre Early cerebral cortex Cortical degeneration, neuronal loss. Hutnick et al., 2009
Olig1-Cre Early OPC progenitors Oligodendrocyte Maturation defect, ER Stress. Moyon et al., 2016
Chx10-Cre Retinal NSCs Defective photoreceptor differentiation. Rhee et al., 2012
Rx-Cre Early retina anlage Photoreceptor degeneration (+Dnmt3a,b). Singh et al., 2017
Dnmt3a Nestin-Cre NPCs/E9-E10 Motor neuron loss. Nguyen et al., 2007
Full K.O. Impaired postnatal differentiation, repression of
neurogenic genes.
Okano et al., 1999; Wu et al.,
2010
CamK2a-Cre93 Excitatory neurons in the mouse
forebrain
Deficits in learning and memory (+Dnmt1). Feng et al., 2010
Plp-CreER(t) Adult OPCs Remyelination impaired. Moyon et al., 2017
Dnmt3b Full K.O. E11.5 Rostral neural tube defects. Okano et al., 1999
Uhrf1 Emx1-Cre E10–E12 Postnatal neurodegeneration, IAP activation. Ramesh et al., 2016
Tet1 Full K.O. Impaired adult hippocampal neurogenesis,
Activity induced gene activation affected,
Memory formation and extinction affected,
When outbred, embryonic lethal (forebrain defects).
Rudenko et al., 2013; Zhang
et al., 2013; Khoueiry et al., 2017
MBD1 Full K.O. Reduced adult hippocampal neurogenesis,
Expression of endogenous viruses,
Aneuploidy,
Impaired LTP in DG.
Zhao et al., 2003
MBD2 Full K.O. Maternal behavior affected in adult mothers. Hendrich et al., 2001
MeCP2 Full K.O. Impaired neuronal maturation in Hippocampus. Smrt et al., 2007
GADD45b Full K.O. Reduced activity induced proliferation of progenitor
cells in the hippocampus.
Ma et al., 2009
modification. Many m5C marks are set early in development
(some even in the germ line, e.g., the imprints), but can often
still be found in somatic cells. This stability is mainly provided
by Dnmt1, which faithfully copies the methylation signature
from the mother strand after each round of DNA replication.
Despite its heritability over cell divisions, DNA methylomes also
undergo significant changes during development, both globally
and locally. A good example for global methylation changes
is occurring during early embryogenesis. Sperm and oocyte
each show high overall methylation levels. During the first cell
divisions of the zygote, DNA methylation gets remodeled. Both,
the maternal and the paternal epigenome get de-methylated,
interestingly, however, with very different dynamics. While
the paternal genome is immediately actively demethylated,
the maternal genome undergoes passive DNA demethylation
during continuous DNA replications (Messerschmidt et al.,
2014). Thereafter, rapid re-methylation occurs on both genomes
with the blastocyst stage, coincidently at the time cells loose
totipotency and specify (Reik et al., 2001). Even though such
dramatic changes are not recurring later in development;
there are plenty local DNA methylation changes occurring in
each cellular lineage, resulting in rather specific methylomes
(Bernstein et al., 2007), which can not only be used to predict
cell type, but even age (Horvath, 2013).
Correlations between DNA Methylation
and Transcription
Early on it has been noticed that some DNAmethylation changes
occurring during development can correlate to transcriptional
changes. The most impressive example, maybe because of
its scale, is the hypermethylation on CpG island promoters
found on inactivated X-chromosomes in female mammalian
cells (Lock et al., 1986; Singer-Sam et al., 1990), while the
genetically identical copies on the active X-chromosome remain
unmethylated. But also promoters of lineage specific genes,
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TABLE 2 | Predictions and experimental support of two models for main function
of DNA-methylation in neurogenesis.
Predictions model 1 Met (+)/unmet (-) Predictions model 2 Met/unmet
Early phenotype – Late (postnatal)
phenotype
+
Appearance of
alternative fate
– Maintenance of
immature hallmarks
+
mRNA up-regulation
of alternative cell fate
genes
−(except GFAP) Failure to
down-regulate
progenitor-specific
mRNas
+
Model 1: DNA-methylation represses alternative fates vs. Model 2: DNA-methylation
represses immature hallmarks to allow full maturation.
like MyoD or various globins, being studied since decades in
primary and immortalized cells, have been found to attract DNA
methylation when the respective genes get downregulated (Jones
et al., 1990). More recently, these concepts have been refined,
as it has been reported that those DNA methylation changes
occurring during development and correlating to transcriptional
differences among tissue types, do rarely involve entire CpG
islands, but more often their mere borders (Irizarry et al., 2009).
It should, however be mentioned, that most methylated sites in
the genome lack predictive value and quite some methylated
loci correlate rather to active transcription than gene silencing
(Niesen et al., 2005; Irizarry et al., 2009; Bahar Halpern et al.,
2014; Zhu et al., 2016).
Genetic Manipulation of DNA Modifications
Further hints into the functional relevance of DNAmodifications
were given by the generation of genetically modified mouse lines
lacking parts of the machinery necessary for their deposition
or removal. Thus, it has been shown that the ability to set
and propagate DNA methylation marks is absolutely essential to
undergo normal embryonic development, since animals lacking
the de novo DNA methyltransferases Dnmt3a and b or the
maintenance methyltransferase Dnmt1 are not viable (Li et al.,
1992; Okano et al., 1999). In contrast to this, the consequences of
losing members of the Tet family of enzymes seem less severe.
ESCs and mice lacking Tet1 [showing a considerable loss of
5hmC (∼20–40%)] are overall viable and only few genes are
significantly mis-regulated (Dawlaty et al., 2011), although it
has been reported that in non-inbred mice Tet1 is essential
for embryogenesis (Khoueiry et al., 2017). A combined loss of
Tet1 and 2 lead to a larger number of intermittent phenotypes,
but mice lacking both proteins can be born viable and fertile
(Dawlaty et al., 2013). Only when all three Tet proteins are
depleted differentiation of pluripotent cells is largely impaired
possibly due to dysregulation of important developmental genes
(Dawlaty et al., 2014). Also depletion of the TDG affects animal
development and accumulation of erroneous DNA methylation
marks which is compatible with its suggested role in the
DNA de-methylation pathway. However, reported changes are
comparatively moderate and involve mostly genes known to
swiftly attract DNA methylation, like the Hox genes (Cortazar
et al., 2011).
Model Systems of DNA Methylation
Function
Several model systems have over the years suggested a
direct role for DNA methylation in transcriptional regulation.
An early example is the in vitro methylation of DNA
which has been shown to prevent transcription of exogenous
copies of globin genes when transfected into mammalian
cells (Busslinger et al., 1983). But also the discovery of
genomic imprinting, a phenomenon of parental specific gene
expression in the embryonic or adult offspring (Barlow et al.,
1991; Bartolomei et al., 1991; Ferguson-Smith et al., 1991),
delivered much needed evidence. It has been found that
loci containing genes with imprinted expression contain a
differentially methylated region, established through differences
in gametic methylation patterns, which serve as imprinting
control regions (ICEs). Genetic approaches resulting in loss of
ICEs, imprinted DMRs or global DNA methylation eliminate
parental specific gene expression, strongly suggesting a direct
functional role for these DNA methylation marks in imprinted
gene regulation (summarized in Barlow and Bartolomei,
2014).
THEORETICAL MODELS OF
TRANSCRIPTIONAL REGULATION BY DNA
MODIFICATIONS
HowDNAmethylation influences transcription was long elusive.
The mechanisms by which DNA methylation of ICEs regulate
imprinted gene expression vary and span from controlling
expression of long non-coding RNAs (Lyle et al., 2000; Seidl
et al., 2006) to interfering with the binding of the common
chromatin protein CTCF on insulator elements (Bell and
Felsenfeld, 2000). The most popular model for the effect of
DNAmethylation entails (consistent with active genes containing
many 5mC residues in their bodies) that DNA methylation
is not directly interfering with transcription. One common
assumption is that it is rather the DNA binding affinity of
transcription factors which is influenced by DNA methylation
(Tate and Bird, 1993; Zhu et al., 2016). While many transcription
factors are thought to be impaired by DNA methylation, some
special transcription factors bind methylated DNA specifically
(Figure 3). In this model, the group of proteins involved in
gene regulation by DNA methylation can be divided in writer
(e.g., the aforementioned DNMTs), eraser (e.g., TET proteins),
and reader proteins. The latter can sense the presence of DNA
methylation marks and respond with altered DNA binding
affinity. Characterization of methyl binding proteins was a
tedious task that is still ongoing today. Firstly discovered was
a family of transcription factors defined by the possession of a
protein domain, shown to prevalently bind to 5mC containing
DNA in vitro. This so called MBD (methyl CpG binding domain)
family of transcription factors has five known members (MBD1,
MBD2, MBD3, MBD4, and MeCP2) (Hendrich and Bird, 1998;
Zhu et al., 2016). Recent technological development has enabled
the genome-wide characterization of their DNA binding features
and elucidated methylation dependent and (particularly in the
Frontiers in Neuroscience | www.frontiersin.org 6 February 2018 | Volume 12 | Article 5
Stricker and Götz DNA Methylation in Neural Development
FIGURE 3 | Proposed molecular effects and consequences of DNA modifications: DNA modifications can be specifically bound by reader proteins. Those can either
have a direct effect or compete with DNA modification independent transcription factors and thus influence transcription through gene activation, repression,
non-coding transcription or insulation.
case of MBD3) independent DNA binding (Baubec et al., 2013).
Complementary approaches helped discovering a large series
of new candidate proteins that in vitro bind at least some of
their possible binding motives specifically in the methylated
form (comprehensively reviewed in Zhu et al., 2016), including
many classical transcription factors like the pioneering factors
Klf4 (Hu et al., 2013) and Kaiso (Prokhortchouk et al., 2001).
A specialty among known methylation binding transcription
factors is Uhrf1, a critical partner of Dnmt1, as it has been
shown to recognize hemi-methylated DNA in its binding motive
(Fang et al., 2016). Recent approaches aiming to discover
reader proteins also for other DNA modifications. These efforts
resulted in candidate lists for 5hmC- (e.g., Uhrf1 and Uhrf2),
5fC- (e.g., members of the NuRD complex), and 5caC-binding
proteins (Frauer et al., 2011; Iurlaro et al., 2013; Spruijt et al.,
2013) and indicated that MeCP2 is binding 5mC in both,
CpG and CpH sites as well as other cytosine modifications
(Mellen et al., 2012; Guo et al., 2014; Gabel et al., 2015).
While much needs to be learnt about the in vivo roles of
these reader proteins and few have been investigated in the
context of neurogenesis and DNA methylation so far, recent
analysis of Uhrf1 supports its key role in DNA-methylation
homeostasis during development and reveals key requirements
for later neuronal differentiation processes (Ramesh et al.,
2016).
Arguments against Global Roles
Classical epigenetic research on model loci has provided
functional examples and mechanistic models; through
epigenomic approaches we can acknowledge how complex
and dynamic epigenomes present themselves. Thus, to date the
most pressing question in epigenetics is not so much, whether
chromatin models of epigenetic gene regulation are correct, but
rather how ubiquitous their functional relevance is; it is, for
example, completely unclear, how many genes (and phenotypes)
are significantly regulated by DNA modifications during
development and disease. This is especially relevant for DNA
methylation, which is rather frequent throughout the genome
and has been extensively mapped. Interestingly, however, quite
some data argues against the idea that the aforementioned
models could be easily translated to any locus or transcriptional
unit.
One of the earliest arguments against a ubiquitous role
for DNA methylation in gene regulation was the finding
that most epigenetically silenced promoters do not appear
heavily methylated during development and, related to this,
that those that do, often gain DNA methylation after gene
expression is lost (Bird, 2002). But there is not only evidence
that developmental gene silencing does not depend on DNA
methylation changes, recent approaches using cancer tissue
derived induced pluripotent stem cells suggest also that removal
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FIGURE 4 | Suggested influences of DNA methylation on neurogenesis. (A) Temporal progression of DNA methylomes might influence the potential of neural stem
and progenitor cells. (B) Cell specific methylomes, here 5mC for simplification, might be responsible for neural cell identities. They could not only influence lineage
choices, but might also simultaneously block alternative fates. (C) Through controlling activity of transposon derived sequences, DNA methylation has been implicated
in contributing to neuronal diversity. (D) Global alterations of DNA modifications often result in cell death during differentiation.
of disease associated DNA methylation marks does not influence
tumorigenicity of cancer cells significantly (Stricker et al., 2013;
Chao et al., 2017). The most convincing argument might,
however, come from genetically engineered embryonic stem
cells lacking all six active copies of DNA methyltransferases
[Dnmt1, Dnmt3a and Dnmt3b, Dnmt3c is not expressed
in embryonic stem cells (Barau et al., 2016)]. These triple
knockout ESCs have undetectable levels of DNA methylation
in their genome. Surprisingly these cells are not only viable
and macroscopically normal; they also possess very few mis-
regulated genes. Moreover, as subsequently revealed by DNAse
hypersensitive site analysis, very few transcription factors change
their binding spectrum once DNA methylation is lost in these
cells (Domcke et al., 2015). Similarly unexpected is the finding,
that the complete loss of TET proteins in differentiating ESCs
only results in a moderate increase of 5mC (Dawlaty et al.,
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2014). These and other findings suggest that our current models
of epigenetic gene regulation might be incomplete and have
to be revisited in order to elucidate the function of DNA
modifications.
DNA METHYLATION IN NEUROGENESIS
The above data prompt the question of how important DNA
methylation would be in development. Development can be
seen as a series of cellular fate restrictions and hence DNA
methylation has been suspected to be involved in these processes.
For example, neural stem cells (NSCs) become progressively
restricted in the generation of neurons and later retain only the
potential to generate glial cells in most brain regions (Figure 4A).
Interestingly, the earliest restriction in fate is spatial and special to
the nervous system as it is mediated by patterning and occurs in
regard to the region the NSCs reside in (Kiecker and Lumsden,
2005). Even prior to the generation of neurons or glial cells,
NSCs are already committed to generate region-specific subtypes,
e.g., excitatory projection neurons in the cerebral cortex. The
second fate restriction is temporal, with neurons of deep cortical
layers generated earlier than neurons of the upper layers of
the mammalian neocortex (Molyneaux et al., 2007). Indeed,
transplantation experiments revealed that early NSCs have the
potential to generate neurons of all cortex layers while late
NSCs loose the potential to generate deep layer neurons (Frantz
and McConnell, 1996), suggesting progressive fate restriction in
regard to neuronal subtype specification. As recently confirmed
with new tools for clonal analysis (Gao et al., 2014), this occurs
via an asymmetric mode of division, by which a NSC generates
sequentially different neuronal subtypes sometimes directly and
sometimes via intermediate, transit-amplifying progenitor cells.
Only after generating all these neurons, the NSC eventually
switches to generate glial cells. Thus, the developmental time
point predicts whether the stem cell progeny commits to a
neuronal or a glial fate (Götz et al., 2016). Not well-understood
is, however, how the sequential fate specification is achieved,
how the previous fates are repressed and how new lineages are
installed.
DNA modifications have been attributed diverse roles
in this process. For example, it has been suggested that
gliogenesis occurs late, because glial genes are repressed during
most of neurogenesis by DNA methylation (Takizawa et al.,
2001). This finding could be expanded to the concept that
cellular methylomes define cell identities directly (Figure 4B).
A certain combination of DNA methylation marks might
safeguard the faithful expression of adequate cellular programs,
while simultaneously repressing inappropriate transcriptional
networks (Figure 4B) (Lee et al., 2014). Accordingly, temporal
changes in DNA methylation may then also allow the sequence
of neuronal fates generated during development (Figure 4A)
(Takizawa et al., 2001; Sanosaka et al., 2009). In agreement with
this is the recent finding that human GABAergic interneurons
and glutamatergic projection neurons indeed differ vastly in
their distribution of DNA modifications (Kozlenkov et al.,
2016). This concept of DNA-methylation fixing fates and
repressing alternatives predicts ectopic fates to be generated
upon interference with DNMTs or TETs, and we will see
below that evidence from mouse mutants does not support this
prediction.
But first we will consider another important role for DNA
methylation, where its repressive role is clearly evident, namely
repressing endogenous retroviral elements (ERVs, Groh and
Schotta, 2017). In all mammalian cells, the highest proportion
of DNA methylation is found on repetitive regions, representing
transposons, retrotransposons, or sequences derived from these
(Crichton et al., 2014). Therefore, it has been frequently suggested
that the main function of DNA methylation might be to silence
these intragenomic parasites (Yoder et al., 1997). However, these
elements might also have important roles during neurogenesis
(Figure 4C). On one hand active transposition could contribute
(Erwin et al., 2014), on the other many regulatory elements
in the genome are evolved from or influenced by endogenous
retroviruses (ERVs) domesticated for gene expression (Rebollo
et al., 2012; Fasching et al., 2015). Thus, it is not unlikely
that genome protective and gene-regulatory roles of DNA
methylation follow similar principles. It has been suggested
that ERVs contribute to the enormous neuronal diversity and
plasticity of the neuronal lineage (Rebollo et al., 2012; Erwin
et al., 2014). Epigenetic mechanisms control ERV activity
and thus regulate local chromatin remodeling, transcription
and potentially their translocation (Figure 4C). This would
imply an important evolutional role to the pronounced
increase of viral elements in the genome during mammalian
phylogeny. However, there are only few experimental options to
unequivocally assess the function of DNA modifications during
cortical development and thus to strengthen these hypotheses,
including: the characterization of the availability of the enzymatic
machinery during development; the epigenomic analysis of DNA
modifications during cortical neurogenesis; and finally, the use of
genetically modified mouse models, possessing altered amounts
or distribution of DNA modifications.
Expression of the DNA Modifying
Machinery during Cerebral Cortex
Neurogenesis
The developing as well as the adult brain expresses most proteins
implicated in the regulation of DNA modifications. Dnmt1 is
ubiquitously present in fetal and full grown mouse brains (Goto
et al., 1994); i.e., even in postmitotic neurons and glia. But also
the de novo methyltransferases are detectable in the nervous
system. Dnmt3a is prominently expressed e.g., in neural stem
and progenitor cells of the ventricular and subventricular zone
of the developing cerebral cortex (E10.5–E17.5), as well as in
postnatal neurons and the oligodendrocyte lineage (Moyon et al.,
2016), while it is mostly absent in astrocytes (Feng et al., 2005).
Dnmt3b can only be detected in the SVZ early (E10.5–13.5), not
later during development (E15.5) (Feng et al., 2005; Moyon et al.,
2016). The newly discovered rodent Dnmt3c lacks expression in
brain as far as we know (Barau et al., 2016). Neural expression
of the three Tet proteins has been reported as well (Khoueiry
et al., 2017), with Tet3 most dominant and Tet1 most feeble, and
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with little modulation between newborn and adults (Szulwach
et al., 2011) or brain regions (Szwagierczak et al., 2010), but
dynamic changes during oligodendrocyte differentiation (Zhao
et al., 2014). Interestingly, Tet3 expression has been found to be
amplified by synaptic activity in cultured hippocampal neurons
(Yu et al., 2015). Additionally, many methyl binding proteins are
present in the nervous system, sometimes in remarkably selective
patterns. A typical example is Mbd1, expressed commonly in
neurons, but not detectable in astrocytes (Zhao et al., 2003). Thus,
the availability and the (at least partially) dynamic expression
of the DNA methylation and de-methylation machinery during
cell fate commitment and differentiation is indeed in line
with potential roles for this epigenomic mark in these
processes.
Epigenomic Distribution of DNA
Modifications during Neurogenesis
First indications about the cell type specific distribution and
dynamics of DNA methylation during neurogenesis (and its
relation to other epigenomic marks and transcription factor
binding) have been gained from differentiation of embryonic
stem cells or neural progenitor cells (Meissner et al., 2008;
Stadler et al., 2011). Profiling of pluripotent and neural stem
cells revealed for example, that regions with low methylation
show the most dynamic DNA methylation changes during
development. Moreover, these are frequently overlapping with
regulatory sequences of important cell fate factors (like Pax6)
and are dependent on transcription factor activity in some tested
cases, as DNAbinding (of the neural repressor REST for example)
is necessary and sufficient to evade high DNA methylation levels
on its binding sites (Stadler et al., 2011).
The recent development of affordable technology for
DNA methylome analysis made the investigation of human
brain samples practicable as well (Figure 2). Large cohorts
of human prefrontal cortex samples revealed the dynamic
changes occurring during development and aging of the brain
(Hernandez et al., 2011; Numata et al., 2012; Jaffe et al., 2016).
These studies indicate that, although methylation differences
are occurring in different scales, either at individual CpGs,
at differentially methylated regions (DMRs) or at even larger
domains, most changes are established during development
and childhood, while methylomes are less plastic later in life.
These findings likely point to differences in cellular composition
rather than developmental dynamics and thus demonstrate
the predicaments when heterogeneous cell populations are
examined. Analysis of more homogeneous cell populations
allow deeper insights, e.g., revealing how in the developing and
adult frontal cortex 5mC patterns distinguish cell types (Lister
et al., 2013) or that methylated CpH sites are almost absent
from (NeuN negative) non-neuronal cells (Lister et al., 2013).
Instead, CpH methylation is generated de novo during neuronal
maturation both in mouse and human cells (Lister et al., 2013;
Guo et al., 2014) and parallels synaptogenesis and neuronal
diversity (Lister et al., 2013; Mo et al., 2015). Remarkably, studies
also indicate that methylation marks occurring in regulatory
regions are more indicative of transcriptional repression when
falling on CpH rather than on CpG sites (Mo et al., 2015).
The first characterization of 5hmC dynamics was linked to
the development of reliable methods mapping this mark
epigenome-wide (Figure 2). Using hMeDIP for example has
shown that in contrast to 5mC, the cellular amount of 5hmC is
significantly increasing when neural stem and progenitor cells
are differentiating to neurons (Hahn et al., 2013). A similar
developmental dynamic has also been detected during ex vivo
analysis of mouse cortices and human brain samples (Szulwach
et al., 2011; Lister et al., 2013; Wen et al., 2014; Vogel Ciernia
and LaSalle, 2016). Interestingly, newly acquired 5hmC often
associates with regulatory elements of neuronal genes (Szulwach
et al., 2011; Wang et al., 2012) and are solely detectable at
CpG sites (Lister et al., 2013). Bisulfite sequencing of DNA
derived from adult mouse dentate granule neurons before
and after synchronous neuronal activation in vivo, revealed
that some DNA methylation marks do not behave as stable
as commonly expected and rather suggested that around 1%
of analyzed 5mC sites fulfill the criteria of activity induced
de-methylation (Guo et al., 2011) with yet elusive function.
Taken together profiling of DNA methylation in mammalian
brain cells from both in vitro and ex vivo models indicate that
diverse cell populations differ significantly in their methylome
and that these changes can swiftly emerge at meaningful
sites, indicating that they could contribute to shape cellular
functions.
Mouse Models
Genetically modified mouse models of all known writers of the
DNAmethylationmachinery have been generated to functionally
test the global relevance of this epigenomic modification. The
full knockout for the de novo methyltransferase Dnmt3a for
example appears overall normal at birth (Li et al., 1992; Okano
et al., 1999), but mice die 4 weeks after birth due to multiple
developmental defects (Okano et al., 1999). It has been suggested
that this is in part due to a disturbed neurogenesis in the
SEZ of the forebrain and the hippocampal dentate gyrus, as
NSCs loose DNA methylation on the gene bodies of neuronal
genes and fail to activate those during differentiation (Wu
et al., 2010). While defects in adult neurogenesis are unlikely
to cause death of the entire organism, these data did reveal
a key role of DNA-methylation in NSC differentiation with
a clear decrease in postnatal neurogenesis. The authors also
suggest that this was due to an increase in gliogenesis and
hence a fate switch, but this is less clear as postnatal and adult
NSCs also express astroglial markers, such as GFAP and some
level of S100b (Beckervordersandforth et al., 2010), making it
impossible to decide whether the increased cell population are
NSCs or astrocytes. Conditional deletions of Dnmt3a in the
developing nervous system (Nes1-Cre) have been reported to
have a shortened lifespan as well, which has been attributed
to postnatal motor neuron loss (Nguyen et al., 2007). Mouse
embryos lacking Dnmt3b exhibit multiple developmental
abnormalities, including rostral neural tube defects, and are
not delivered to term (Okano et al., 1999). Thus, normal neural
development is (at least partially) dependent on the presence
of both de novo methyltransferases. Although full knockouts of
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Tet1 have been reported to be born overall normal (Dawlaty
et al., 2011), recently newmutant alleles have been generated that
are lethal during embryogenesis when outbred, at least partially
due to “deformities in forebrain development associated with
incomplete closure of the anterior neuropore” (Khoueiry et al.,
2017).
Dnmt1 full knockout embryos have strong phenotypes and
are early embryonic lethal (Li et al., 1992), while conditional
deletions show a remarkably specific effect. Depletion of this
methyltransferase in postmitotic neurons, using the CamK-Cre
line, neither affected DNA methylation levels significantly, nor
influenced postnatal survival of the animals, raising questions,
which role Dnmt1 expression might play in postmitotic cells
(Fan et al., 2001). Deletion of Dnmt1 in neural progenitors
during development results in animal death (hours after birth in
animals with high recombination rates; and significant neuronal
loss in animals with reduced Cre activity) (Fan et al., 2001).
Although after deletion of DNMT1 in the developing CNS up-
regulation of some glial genes, like GFAP, have been observed,
this occurred only at the end of neurogenesis and hence onset
of gliogenesis in vivo, despite much earlier loss of DNMT1
using the Nestin-Cre line (Fan et al., 2005). Importantly,
genomewide expression analysis should reveal best whether
true fate changes occur—nowadays ideally done at single cell
level. However, RNA-seq data do not reveal any indication
for a fate switch when done early (E15 cortex Emx1Cre/Uhrf1,
Ramesh et al., 2016) and highlight rather neuronal death as
the main phenotypic consequence of hypomethylation in the
brain and the GFAP increase as an indication of gliosis due
to postnatal neuronal cell death when done later (Hutnick
et al., 2009; Ramesh et al., 2016). Cortical degeneration appears
not to be a consequence of altered fates, but rather due to
another key role of DNA methylation: to stably silence repetitive
elements [for Dnmt1 in particular ERVs like the intracisternal A-
particle retroviruses (IAPs); (Walsh et al., 1998; Hutnick et al.,
2009)]. Conditional deletions of the Dnmt1 partner Uhrf1 during
cortical neurogenesis confirmed these findings and showed
that despite profound demethylation primarily IAPs were de-
repressed and that this is accompanied by postnatal neuronal
degeneration (Ramesh et al., 2016). Interestingly, IAPs were
up-regulated already at E12, yet neuronal death occurred only
after the first postnatal week when neurons become functionally
active. Indeed, many genes encoding for proteins involved in
neuronal activity were dysregulated supporting again a role of
DNAmethylation in regulating neronal differentiation processes.
Notably, despite loss of at least 25% of global DNA methylation
no ectopic fates such as premature gliogenesis were observed in
these mutants. Moreover the data indicated, that it is not the
loss of DNA methylation, but rather the gain of 5hmC, which
results in IAP activation during brain development, since the
process can be rescued by simultaneous reduction of Tet2 and
Tet3 (Ramesh et al., 2016). Thus, depleting key enzymes for DNA
methylation maintenance or removal throws the epigenome out
of balance, resulting in rather specific consequences for neuronal
maturation and survival (Figure 4D). Similar to the phenotypes
observed in brain development, deletion of DNMT1 in the retina
and in oligodendrocyte progenitor cells show profound defects
in the final maturation of photoreceptors and oligodendrocytes,
respectively, but no generation of alternative fates (Table 1).
Development continues to some extent also in the adult brain,
both in adult neurogenesis but also in the ongoing synaptic
plasticity that constantly re-forms new synaptic connections.
DNA modifications have also accredited functional roles in these
processes including information storage and providing (in adult
NSC niches) new mature neurons (Ninkovic and Götz, 2013).
In the late 60s, an open debate was started, how neurons would
be able store memory information for life, while the stability
of the molecular building blocks of these cells is many orders
of magnitudes shorter. Interestingly, DNA modifications, due
to their mode of inheritance, have been frequently suggested as
prime candidates for memory storage (Griffith andMahler, 1969;
Crick, 1984). Already in 1969 J.S. Griffith suggested “that the
physical basis of memory could lie in the enzymatic modification
of the DNA of nerve cells. It might be worth looking to see
if there are unusual bases specific to nerve cell DNA, but in
the absence of evidence to that effect, a plausible suggestion
would be that the modification consists of methylation (or
demethylation)” (Griffith and Mahler, 1969). During the last
decades this concept has been regularly revived (Meagher, 2014).
Indeed we know now, that the brain is, compared to other organs,
especially active in remodeling DNA methylation patterns and
a prominent source of scarce DNA modifications. For example,
non-CpGmethylation is common in neurons in contrast to other
differentiated cell types (Guo et al., 2014), its occurrence is highly
linked to the neuronal expression of Dnmt3a, as knockdown of
this de novo methyltransferase abolishes CpH methylation (but
not CpG methylation, which is mainly dependent on Dnmt1)
(Guo et al., 2014). However, maybe the most surprising results
stem from genetically modified, overexpression or knockdown
mouse models of writer, reader, and eraser proteins of DNA
modifications, resulting either in phenotypes affecting memory
formation or consolidation [Tet1 (Kaas et al., 2013; Rudenko
et al., 2013; Zhang et al., 2013), Dnmt1, Dnmt3a, and Dnmt3a2
(Miller and Sweatt, 2007; Feng et al., 2010; Oliveira et al., 2012,
2016)], emotional or maternal behavior [Dnmt3a (LaPlant et al.,
2010), Mbd2 (Hendrich et al., 2001)], LTP [Mbd1 (Zhao et al.,
2003)], or adult neurogenesis in the hippocampus [GADD45b
(Ma et al., 2009), Tet1 (Zhang et al., 2013), Mbd1 (Zhao et al.,
2003), Mecp2 (Smrt et al., 2007)] indicating that neuronal
maturation or specific neuronal functions in particular neuronal
plasticitymight indeed be dependent on normal availability of the
DNA modification machinery.
Human Model Systems of DNA
Modifications and Brain Diseases
Interestingly, several neurodevelopmental disorders have
also been linked to proteins involved in the regulation of
DNA modification emphasizing their relevance in cerebral
cortex development. Rett syndrome, a rare X-linked postnatal
neurological disorder, was the first among this group, when it
was discovered in 1999 that it is caused by mutations in the
DNA methylation binding protein MeCP2 (Amir et al., 1999).
In the meantime many more diseases have been added: for
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example, the immunodeficiency, centromeric region instability,
and facial anomalies syndrome (ICF), caused by mutations in
DNMT3B is often associated with mild cognitive and neurologic
defects (Hagleitner et al., 2008). Similarly, childhood overgrowth
syndrome, a developmental disorder resulting (amongst other
phenotypes) in intellectual disabilities, is caused by mutations
of the DNMT3A gene (Tatton-Brown et al., 2014). Moreover,
it has been recently shown that brain tumors, use stem cell
factors to interfere with astrocyte differentiation and the DNA
methylation machinery (Bulstrode et al., 2017). Indeed some
brain tumors are even driven by mutations in the isocitrate
dehydrogenase 1 (IDH1). Mutations of this enzyme result in
tumor cells which contain severely elevated global levels of DNA
methylation. The reason for this is the abnormal accumulation of
2-hydroxyglutarate (2-HG), a powerful inhibitor of TET activity
(Turcan et al., 2012). Thus, DNA methylation clearly also affects
human NSC differentiation even though much more needs to be
learnt about the exact mechanisms.
OUTLOOK
Taken together, the above mentioned experimental tests on the
role of DNA methylation in cerebral cortex development do
not lend much support to the model that it serves to repress
alternative fates (Table 2). Besides GFAP up-regulation (Kim
et al., 2016) there is not much evidence for aberrant glial
fate instruction, including in genome-wide expression analysis
(Hutnick et al., 2009; Ramesh et al., 2016), and no ectopic fate
choices have been observed in any of the above mutants. Rather,
a common theme is cell death, due to either the failure to fully
differentiate and/or to repress repetitive elements (Ramesh et al.,
2016), quite similar to what had been described in the postnatal
retina (Rhee et al., 2012). Thus, the hypothesis that DNA
methylation represses alternative fates has to be questioned, while
the role in differentiation receives more support. Indeed, in the
few studies of mouse mutants that examined the transcriptome,
many aspects of immature cells, such as cell proliferation, fail
to be repressed at later stages along with the failure to up-
regulate genes involved in synaptic maturation. According to
Wu et al., Prc2 mediated mechanisms could be involved in
these processes as they showed that Dnmt3a-mediated DNA
methylation adjacent to H3K4me3 high promoters interferes
with Prc2 binding and H3K27me3 and thereby mediates up-
regulation of neuronal progenitor genes (Wu et al., 2010). In
addition or alternatively, Tet-mediated roles could be involved
as described above from the Uhrf1 study (Ramesh et al., 2016).
However, much remains to be understood about the repressive
function of DNA-methylation in regard to differentiation and
neuronal maturation. This is particularly evident from the
poor correlation between changes in DNA-methylation and
transcription. Further follow-up studies on the transcriptional
changes that are crucial for the phenotypes aiming to correlate
these to epigenetic mechanisms will hold the key to better
mechanistic understanding of the mouse mutant phenotypes.
Indeed, so far virtually none of these phenotypes have been
linked with precise sites in the genome being de-methylated,
but always groups of sites, regions, or genes. This can be
confounding as for example many methylation marks might
have opposing roles in the body, such as maternal and paternal
imprints that, respectively, reduce or activate growth (Barlow and
Bartolomei, 2014). Thus, to elucidate which roles the epigenome
plays in the brain, first we have to differentiate essential from
specific and both from bystander marks, dissecting thereby
secondary from causal DNA modifications. This can now be
done by new options, which allow manipulating individual
DNA modifications to evaluate their immediate causal effect
on transcription and cell behavior. This new experimental
field, collectively termed epigenome editing (Stricker et al.,
2017), promises to deliver a better understanding of the role
DNA modifications play during cortex development. Epigenome
editing is mainly based on modified versions of the bacterial
CRISPR system, allowing to precisely target any genomic locus in
any cell. Fusing DNA modifying enzymes to dCas9 (the nuclease
deficient targeting protein) has been proven to locally set or
remove DNA modifications. So far, Tet1 and Dnmt3a have been
used most prominently to show that DNA methylation on the
accurate locus can indeed influence transcription of a gene close
by (Amabile et al., 2016; Choudhury et al., 2016; Liu et al., 2016;
Xu et al., 2016). However, we are still far from a comprehensive
view about gene regulation by DNA modifications, especially
during brain development, but studies successfully manipulating
histone marks indicate this will be promising approach to study
neurogenesis (Albert et al., 2017). Thus, tools of epigenetic
engineering allowing methylating or demethylating specific
genomic sites to investigate their function directly will help
to causally link methylation of specific genes with functional
phenotypes. This aim is more relevant than ever, as epigenome
wide association studies (EWAS) suggest new targets for a variety
of diseases on a regular basis (Stricker et al., 2017).
CONCLUSION
While much remains to be done, experimental tests propose
already a revision of the concept that DNA methylation would
repress alternative fates (Tables 1, 2). Rather DNA methylation
appears generally required for repression of ERVs, even though
with striking cell type specificity. A further general concept
that emerged is its role in orchestrating cell differentiation, but
within a given lineage (neurons, oligodendrocyte progenitors,
Table 2). The involvement of splicing as effector of changes in
DNA methylation is an exciting new angle to pursue with more
precise epigenetic engineering tools. Distinguishing essential
from specific, and causal from secondary marks will be essential
for neuro-epigenetics. New approaches promise to answer long
outstanding questions and will likely facilitate the discovery that
DNA modifications might have new unexpected roles in the
brain.
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